The symptoms of menopause can significantly affect a woman's quality of life. Hormone replacement therapy or menopausal hormone therapy (HRT or MHT) is the name for a number of hormone therapies that can be used to treat the symptoms of menopause. In this podcast, Associate Professor Nicholas Wilcken discusses some of the risks and benefits of hormone replacement therapy and why it's important that women also discuss their symptoms with their doctor. Learn more:

Approximately 5-10% of breast cancers are due to a strong family history or a genetic mutation such as BRCA1 or BRCA2. So, if you have a strong family history of breast cancer, you may be questioning whether you should have genetic testing. In this podcast, Associate Professor Nicholas Wilcken talks about genetic testing: who should have it, who shouldn't, and why genetic counselling is important for those who do. Find out more: www.breastcancertrials.org.au

New research breakthroughs are always in the news, but it can take years before these treatments are used in the clinic. So why does it take so long? Breast Cancer Trials Board Member Professor Christobel Saunders explains why the process is a long one and the different phases of clinical trials. Learn more: www.breastcancertrials.org.au

Breast cancer clinical trials research has played an important role in the improvements to treatments and survival rates, particularly over the last 30 years. In this podcast, Professor Christobel Saunders explains what some of the key achievements of this research, which have led to advances in the treatment of breast cancer. Find out more: www.breastcancertrials.org.au

Associate Professor Nicholas Wilcken was the Study Chair of the HERA clinical trial which tested the drug Herceptin and delivered a major breakthrough for women with HER2 positive breast cancer. In this podcast, Associate Professor Wilcken discusses what happens when a drug is proven effective in a clinical trial. Find out more: www.breastcancertrials.org.au

Finding a clinical trial that is right for you, or for a family member or friend, has never been easier. In this podcast Professor Bruce Mann explains the two main paths to participating in a clinical trial and what's involved once you're on a trial. Find our more: www.breastcancertrials.org.au

Breast cancer treatments are constantly evolving and improving because of clinical trials research. Each clinical trial builds on the knowledge gained from past research. In this podcast, Breast Cancer Trials Board Chair Professor Bruce Mann explains how breast cancer surgery is a good example of the benefits that come from clinical trials. Find out more: www.breastcancertrials.org.au

Tameeka Jones was only in her 20s and had a three-year-old daughter when she was diagnosed with breast cancer. Tameeka is a participant in the ELIMINATE clinical trial, which is investigating whether combining two breast cancer treatments before surgery is more effective than one alone, in women diagnosed with large oestrogen receptor positive breast cancer. In this podcast, she tells us her experience participating in a clinical trial. Find out more: www.breastcancertrials.org.au

A diagnosis of breast cancer at the age of 32 was a big shock for Natasha Eaton who initially thought it would mean she wouldn't be able to have children. Natasha was a participant on the POEMS clinical trial which was a breakthrough study for women with breast cancer and was aimed at preserving a woman's fertility during her cancer treatment. In this podcast she discusses her experience participating in a clinical trial. Find out more: www.breastcancertrials.org.au

Women have played an important role in the development and conduct of the Breast Cancer Trials research program for many years. Not only was the Consumer Advisory Panel the first committee of its type in Australia, but it has become a model for other research groups to involve consumers. In this podcast, Chair of the Breast Cancer Trials Consumer Advisory Panel Leonie Young, explains the role that CAP plays, to ensure a consumer perspective is provided from the very early planning stages of a breast cancer clinical trial. Find out more: www.breastcancertrials.org.au